North America Urinalysis Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 1.62 Billion |
 Marktgröße (Prognosejahr) | USD 2.64 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
North America Urinalysis Market, By Testing Type (Urine Biochemistry Testing and Urine Biochemistry Testing), Product (Instruments and Consumables), Test Type (Biochemical, Pregnancy and Fertility, and Sediment), Modality (Portable, Standalone, Table Top, Bench Top, and Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, and Others), End User (Hospital, Laboratory, Home Care Settings, and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2031.
North America Urinalysis Market Analysis and Size
A study conducted by the National Center for Biotechnology Information (NCBI) in November 2021 revealed that around 40% of women in the U.S. are at risk of developing a urinary tract infection (UTI) at some point in their lives, primarily due to the high prevalence of uncomplicated UTIs. In addition, a report released by the National Kidney Foundation in 2021 highlighted that CKD is the leading cause of death, surpassing prostate and breast cancer. Approximately 37.0 million people in the U.S., which accounts for about 15% of the adult population, are predominantly affected by CKD.
North America urinalysis market size was valued at USD 1.62 billion in 2023 and is projected to reach USD 2.64 billion by 2031, with a CAGR of 6.3% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016 - 2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Testing Type (Urine Biochemistry Testing and Urine Biochemistry Testing), Product (Instruments and Consumables), Test Type (Biochemical, Pregnancy and Fertility, and Sediment), Modality (Portable, Standalone, Table Top, Bench Top, and Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, and Others), End User (Hospital, Laboratory, Home Care Settings, and Others), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), and Analyticon Biotechnologies GmbH (Germany) |
|
Market Opportunities |
|
Market Definition
Urinalysis is a diagnostic test that examines urine's physical, chemical, and microscopic properties. It is commonly used to assess the health of the urinary system and other organs, and to diagnose various medical conditions. Urinalysis can provide information about hydration levels, kidney function, urinary tract infections, and the presence of substances, such as glucose or proteins in the urine.
Urinalysis Market Dynamics
Drivers
- Rise in Chronic Kidney Disease (CKD) Cases
CKD is a serious condition characterized by gradually losing kidney function over time. The incidence of CKD increases with rise in prevalence of risk factors such as diabetes, hypertension, and obesity. Urinalysis plays a crucial role in the monitoring and managing CKD, as it can help healthcare providers assess kidney function, detect proteinuria (a common sign of kidney damage), and monitor disease progression. The rise in CKD cases globally is a significant driver for the urinalysis market.
- Rising Geriatric Population
With the increasing number of aging people, the risk of developing kidney disease increases, making regular monitoring of kidney function essential. Urinalysis is a valuable diagnostic tool for assessing kidney health and detecting early signs of kidney disease in the elderly population. The aging population is more susceptible to urinary tract issues and kidney-related diseases, leading to a higher demand for urinalysis tests for early detection and monitoring of these conditions.
Opportunities
- Technological Advancements in Urinalysis Devices
The urinalysis field is experiencing a wave of technological innovation, with new developments such as smartphone-based urinalysis apps and wearable devices. These advancements allow for convenient and efficient monitoring of urinary parameters, enabling individuals to track their health in real time. Smartphone apps can analyze urine samples using the phone's camera and provide instant results. On the other hand, wearable devices offer continuous monitoring of urinary parameters, providing valuable data for individuals and healthcare professionals. These technological innovations not only improve the accessibility of urinalysis but also open up new possibilities for remote monitoring and personalized healthcare.
- Rise in Home Healthcare
The shift towards home healthcare and self-monitoring needs convenient, user-friendly, and suitable solutions outside traditional healthcare settings. These solutions often include user-friendly testing kits allowing individuals to collect and analyze urine samples, with results available within minutes. In addition, digital platforms and telehealth services are being integrated with urinalysis devices, enabling individuals to share their results with healthcare professionals remotely. This home-based healthcare is creating more market opportunities.
Restraints/Challenges
- High Cost of Urinalysis Tests
The expenses involved in purchasing the necessary equipment and supplies, conducting the tests, and interpreting the results can be prohibitive for healthcare facilities and individuals alike. This can lead to a lower uptake of urinalysis tests, especially among low-income populations who may be unable to afford them. The cost associated with urinalysis tests can pose a significant barrier to their adoption, particularly in developing countries with limited healthcare budgets.
- Limited Access to Healthcare Services
In many developing countries, healthcare facilities are concentrated in urban areas, leaving those in rural and remote areas with limited access to diagnostic services. This lack of access can be a major barrier to adopting urinalysis tests, as individuals may have to travel long distances to reach a healthcare facility that offers them. Limited access to healthcare services, especially in rural and remote areas, can also hinder the utilization of urinalysis tests.
This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In January 2023, Siemens Healthineers acquired Acon Laboratories, a prominent supplier of urinalysis consumables. This acquisition bolstered Siemens Healthineers' position in the urinalysis market, enabling the company to enhance its product offerings and tap into new customer segments
- In September 2022, Sysmex Corp. unveiled its UF-1500 Fully Automated Urine Particle Analyzer, designed for urine sediment testing. Additionally, in 2022, the National Kidney Foundation raised over USD 600 million to support research, provide patient care, and advocate for individuals with kidney disease
- In August 2021, myLAB Box, the nation's pioneering at-home testing-to-treatment service, unveiled its latest offering: an at-home colorectal cancer screening test. This new test, which is painless and user-friendly, aims to assist physicians in detecting possible signs of colon cancer in both men and women. As with all myLAB Box test kits, samples can be easily collected at any time and from anywhere
Urinalysis Market Scope
The market is segmented on the basis of testing type, product, modality, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Testing Type
- Urine Biochemistry Testing
- Urine Biochemistry Testing
Product
- Instruments
- Biochemical Urine Analyzers
- Automated biochemical analyzers
- Semi-automated Biochemical Analyzers
- Automated Urine Sediment Analyzers
- Microscopic Urine Analyzers
- Flow-Cytometric Urine Analyzers
- Point-Of-Care Urine Analyzers
- Consumables
- Dipsticks
- Reagents
- Disposables
- Pregnancy and Fertility Kits
Modality
- Portable
- Standalone
- Table Top
- Bench Top
- Others
Application
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Pregnancy and Fertility
- Others
End User
- Hospital
- Laboratory
- Home Care Settings
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Urinalysis Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, testing type, product, modality, application, end-user, and distribution channel as referenced above.
The countries covered in the market are U.S., Canada, and Mexico.
The U.S. is expected to dominate the market and also be the fastest growing country due to rising numbers of urinalysis procedures and the growing adoption of urinalysis for treating liver disease and urinary tract infections. Further, the strategic initiatives pursued by major players, including the implementation of licensing agreements, are also a major driver for market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The urinalysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for urinalysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the urinalysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Urinalysis Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT Medical Electronic Group Co., Ltd. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatech Scientitfic E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon Biotechnologies GmbH (Germany)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
